welcomes you to the new, improved website!The authors analyzed the outcomes of the continuous-flow left ventricular assist devices. The study includes 105 patients supported with HM2 (N=54), HM3 (N=25), and HW (N-26). Eighteen-month data suggested that HM3 had a better prognostic and adverse-event profile over other devices.
You are here:
An 18-Month Comparison of Clinical Outcomes Between Continuous-Flow Left Ventricular Assist Devices
Submitted by: Emily Robinson
Source: European Journal of Cardio-Thoracic Surgery
Source URL: https://doi.org/10.1093/ejcts/ezz268
Keywords:
Author(s): Osnat Itzhaki Ben Zadok, Ben Ben-Avraham, Aviv Shaul, Yoav Hammer, Victor Rubachevski, Dan Aravot, Ran Kornowski, Tuvia Ben-Gal
